Evidence map›Paper›PMID 41403435›Full record

ArticleFrontiers in pharmacology2025

Decoding the therapeutic potential mechanism of

Zheng Wu, Jiwei Zhao, Wen Wang, Yuan Dong, Taotao Zhou, Yide Feng, Yalan Deng, Yingmei Feng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zheng WuBeijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Jiwei ZhaoBeijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Wen WangDepartment of Experimental Animal Laboratory, Xuanwu Hospital Capital Medical University, Beijing, China.
Yuan DongBeijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Taotao ZhouBeijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Yide FengBeijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Yalan DengBeijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Yingmei FengBeijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: This study employed a network pharmacology approach combined with molecular docking to systematically explore the active components of Results: A total of 11,663 PD-related targets were identified from multiple databases, with 185 overlapping targets obtained from active components of Conclusion:

Indexed as

Cornus officinalismechanism of actionmolecular dockingParkinson’s diseasetraditional Chinese medicine

Identifiers

PMID41403435
PMCPMC12702959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.